Search Constraints
« Previous |
1 - 20 of 81
|
Next »
Search Results
Select an image to start the slideshow
The synthesis & optimisation of irreversible ITK inhibitors as a potential new treatment for severe asthma
1 of 20
Automated, quantitative process analysis by NMR
2 of 20
Pharmacological characterisation of the 5-HT receptors present on mouse and human hepatic stellate cells and their role in liver fibrosis
3 of 20
New dose estimation methods and their application in early drug discovery using intravenous, oral and inhaled routes of administration for new chemical entities
4 of 20
Development of small molecule splice-switchers as inducers of apoptosis
5 of 20
Approaches to lead generation for idiopathic pulmonary fibrosis targets
6 of 20
New route investigation and process development in the synthesis of GSK221149
7 of 20
The design and synthesis of targeted BET inhibitors
8 of 20
Development towards prospective modelling of in vivo rabbit QTc prolongation
9 of 20
Structure-guided approaches to the design of novel autotaxin inhibitors
10 of 20
Development of photoaffinity labelling technologies for small molecule drug discovery - a case study targeting bromodomains
11 of 20
Application of electrochemical based sensors in support of toxicokinetic and pharmacokinetics
12 of 20
The application of flow chemistry to the synthesis of pharmaceutically privileged heterocycles
13 of 20
Application of bioisosteres to modulate molecular properties in medicinal chemistry
14 of 20
The design and synthesis of chemical probes for non-BET bromodomains
15 of 20
Development of chemical probes for non-BET bromodomains
16 of 20
Use of fragment-based drug discovery to identify novel drug molecules for challenging biological targets, including protein-protein interactions
17 of 20
Investigation and application of 3-Oxabicyclo[4.1.0]heptane as a mechanistic target of rapamycin (mTOR) kinase hinge binding fragment
18 of 20
The development of small molecules for treatment of idiopathic pulmonary fibrosis (IPF)
19 of 20
The design, synthesis and optimisation of epigenetic mechanism inhibitors
20 of 20